Gainers
- Palisade Bio PALI shares increased by 111.8% to $6.82 during Friday's regular session. The current volume of 67.8 million shares is 4351.8% of Palisade Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $9.7 million.
- Dermata Therapeutics DRMA shares increased by 80.34% to $0.36. As of 12:30 EST, this security is trading at a volume of 37.6 million shares, making up 4522.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 million.
- F-star Therapeutics FSTX stock moved upwards by 45.96% to $5.97. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 2.9 million, which is 934.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $131.2 million.
- 180 Life Sciences ATNF shares increased by 37.33% to $2.6. Trading volume for 180 Life Sciences's stock is 16.8 million as of 12:30 EST. This is 1149.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
- Kala Pharmaceuticals KALA stock rose 35.86% to $33.75. Trading volume for this security as of 12:30 EST is 11.2 million, which is 765.9% of its average full-day volume over the last 100 days. The company's market cap stands at $53.8 million.
- Salarius Pharmaceuticals SLRX shares rose 33.05% to $1.57. Salarius Pharmaceuticals's stock is trading at a volume of 240.1K shares as of 12:30 EST. This is 478.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
Losers
- Hoth Therapeutics HOTH shares fell 25.4% to $8.0 during Friday's regular session. Trading volume for Hoth Therapeutics's stock is 4.7 million as of 12:30 EST. This is 798.3% of its average full-day volume over the last 100 days. The company's market cap stands at $10.4 million.
- Nuwellis NUWE stock fell 16.92% to $10.07. As of 12:30 EST, Nuwellis's stock is trading at a volume of 405.9K, which is 184.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
- Revelation Biosciences REVBU shares declined by 16.67% to $0.2.
- Reshape Lifesciences RSLS shares decreased by 16.28% to $6.43. Reshape Lifesciences's stock is trading at a volume of 81.1K shares as of 12:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
- Summit Therapeutics SMMT shares fell 13.38% to $4.6. As of 12:30 EST, this security is trading at a volume of 3.1 million shares, making up 37.6% of its average full-day volume over the last 100 days. The company's market cap stands at $926.0 million.
- Femasys FEMY stock fell 13.15% to $0.72. The market value of their outstanding shares is at $8.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
DRMADermata Therapeutics Inc
$1.359.76%
FEMYFemasys Inc
$1.102.80%
HOTHHoth Therapeutics Inc
$0.7900-3.36%
KALAKala Bio Inc
$6.111.83%
NUWENuwellis Inc
$1.114.72%
PALIPalisade Bio Inc
$1.67-4.57%
RSLSReshape Lifesciences Inc
$4.628.45%
SLRXSalarius Pharmaceuticals Inc
$1.676.37%
SMMTSummit Therapeutics Inc
$19.001.77%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in